{"id":1243,"date":"2025-06-10T17:36:55","date_gmt":"2025-06-10T17:36:55","guid":{"rendered":"https:\/\/accelia.vc\/?post_type=news_post&p=1243"},"modified":"2025-11-28T15:47:38","modified_gmt":"2025-11-28T15:47:38","slug":"eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system","status":"publish","type":"news_post","link":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/","title":{"rendered":"Eli Health raises $12M Series A for instant hormone monitoring system"},"content":{"rendered":"

New York, June 10, 2025 – <\/strong>Eli Health has closed a $12 million Series A funding round led by BDC Capital\u2019s Thrive Venture Fund to accelerate deployment of its Hormometer, the instant hormone monitoring system that delivers results from saliva to mobile app within minutes. The New York-based company has raised $20 million to date and plans to launch its platform in beta this year, beginning with cortisol monitoring. The funding will support production scaling, additional biomarker development, and expansion of the company\u2019s personalized health platform.<\/p>\n

Eli Health addresses a significant health gap affecting 60% of adults who experience hormone imbalance symptoms. The company focuses initially on cortisol, a stress hormone with dysregulation affecting one in three adults. Traditional lab tests miss daily hormone fluctuations, making it difficult to understand symptoms and implement appropriate lifestyle adjustments.<\/p>\n

\u201cHormones regulate nearly every major system in the body\u2014governing stress response, sleep, cognitive and physical performance, metabolism, immune function, and much more. But until now, this data has been largely invisible,\u201d said Marina Pavlovic Rivas<\/strong>, Eli Health co-founder and CEO. \u201cWe\u2019ve created the real-time interface to the human body, where hormone tracking is as easy as checking your temperature and as quick as brushing your teeth.\u201d.<\/p>\n

The Hormometer enables users to check hormone levels instantly using saliva samples and smartphone technology, providing results alongside personal trends and AI-powered recommendations through the Eli Health app. The device requires no laboratory processing or sample shipment.<\/p>\n

Eli Health completed more than five years of research and development, securing 12 patent-pending innovations across biochemistry, hardware, software, artificial intelligence, and endocrinology. The company has achieved FDA registration and established in-house manufacturing capabilities to meet commercial demand. The platform earned CES 2025 \u201cBest of Innovation in Digital Health\u201d. Subscription plans begin at $8 per test with a 12-month commitment, with flexible options available.<\/p>\n

 <\/p>\n

\u201cHormonal health is emerging as one of the most important frontiers in personal wellness,\u201d said Mona Minhas<\/strong>, Partner at BDC Thrive Venture Fund and Board Member at Eli Health. \u201cEli Health leveraged this shift early and, through years of focused execution, built the science, technological platform, and manufacturing infrastructure to lead the category.\u201d<\/p>\n

Additional investors include California-based Muse Capital, which continues serving on the company\u2019s board, along with TELUS Global Ventures, Foreground Capital, Rocana Ventures, Accelia Capital, Garage Capital, Swizzle Ventures, IKJ Capital, Next Blue, Real Ventures, and Leva Capital.<\/p>\n

\u201cFor the first time in history, we\u2019ll have a continuous, real-world view of hormone patterns at scale,\u201d said Assia Grazioli-Venier<\/strong>, Founding Partner at Muse Capital and Board Member at Eli Health. \u201cThat kind of insight doesn\u2019t just improve daily health, it redefines the very infrastructure of care.\u201d<\/p>\n

 <\/p>\n

Eli Health operates a private beta program with early adopters currently using the Hormometer for health optimization. The company also maintains a waitlist for progesterone monitoring, the next hormone planned for platform integration, and plans public launch later this year.<\/p>\n","protected":false},"excerpt":{"rendered":"

Eli Health has closed a $12 million Series A funding round led by BDC Capital\u2019s Thrive Venture Fund to accelerate deployment of its Hormometer, the instant hormone monitoring system that delivers results from saliva to mobile app within minutes. The New York-based company has raised $20 million to date and plans to launch its platform in beta this year, beginning with cortisol monitoring. The funding will support production scaling, additional biomarker development, and expansion of the company\u2019s personalized health platform.<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"acf":[],"yoast_head":"\nEli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital\" \/>\n<meta property=\"og:description\" content=\"Eli Health has closed a $12 million Series A funding round led by BDC Capital\u2019s Thrive Venture Fund to accelerate deployment of its Hormometer, the instant hormone monitoring system that delivers results from saliva to mobile app within minutes. The New York-based company has raised $20 million to date and plans to launch its platform in beta this year, beginning with cortisol monitoring. The funding will support production scaling, additional biomarker development, and expansion of the company\u2019s personalized health platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Accelia Capital\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-28T15:47:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/\",\"url\":\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/\",\"name\":\"Eli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital\",\"isPartOf\":{\"@id\":\"https:\/\/accelia.vc\/en\/#website\"},\"datePublished\":\"2025-06-10T17:36:55+00:00\",\"dateModified\":\"2025-11-28T15:47:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/accelia.vc\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli Health raises $12M Series A for instant hormone monitoring system\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/accelia.vc\/en\/#website\",\"url\":\"https:\/\/accelia.vc\/en\/\",\"name\":\"Accelia Capital\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/accelia.vc\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/","og_locale":"en_US","og_type":"article","og_title":"Eli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital","og_description":"Eli Health has closed a $12 million Series A funding round led by BDC Capital\u2019s Thrive Venture Fund to accelerate deployment of its Hormometer, the instant hormone monitoring system that delivers results from saliva to mobile app within minutes. The New York-based company has raised $20 million to date and plans to launch its platform in beta this year, beginning with cortisol monitoring. The funding will support production scaling, additional biomarker development, and expansion of the company\u2019s personalized health platform.","og_url":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/","og_site_name":"Accelia Capital","article_modified_time":"2025-11-28T15:47:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/","url":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/","name":"Eli Health raises $12M Series A for instant hormone monitoring system - Accelia Capital","isPartOf":{"@id":"https:\/\/accelia.vc\/en\/#website"},"datePublished":"2025-06-10T17:36:55+00:00","dateModified":"2025-11-28T15:47:38+00:00","breadcrumb":{"@id":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/accelia.vc\/en\/news_post\/eli-health-raises-12m-series-a-for-instant-hormone-monitoring-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/accelia.vc\/en\/"},{"@type":"ListItem","position":2,"name":"Eli Health raises $12M Series A for instant hormone monitoring system"}]},{"@type":"WebSite","@id":"https:\/\/accelia.vc\/en\/#website","url":"https:\/\/accelia.vc\/en\/","name":"Accelia Capital","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/accelia.vc\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/accelia.vc\/en\/wp-json\/wp\/v2\/news_post\/1243"}],"collection":[{"href":"https:\/\/accelia.vc\/en\/wp-json\/wp\/v2\/news_post"}],"about":[{"href":"https:\/\/accelia.vc\/en\/wp-json\/wp\/v2\/types\/news_post"}],"wp:attachment":[{"href":"https:\/\/accelia.vc\/en\/wp-json\/wp\/v2\/media?parent=1243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}